How To Cope With Colon Cancer
One of the more aggressive and worst types of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that it is usually detected in its late stages when it is extremely hard to do anything about it.
As the effects of neuroendocrine colon cancer become visible only in the most advanced stages the survival rate drops at an alarming rate. Existing tumours are malignant and are usually detected with distant metastases. Surveys show reports tell us that most of the cases of neuroendocrine cancer end in death.
Though the possibilities of neuroendocrine carcinoma in colon are very rare, if unfortunately one is affected by this disease, the health of the patient appears even worse than those who are suffering from adenocarcinoma.
Research reveals that the results of this form of cancer do not differ with age, sex or tumour location. Though neuroendocrine colon carcinoma depends on which stage the tumour is in the usual trends reveal that most people show that generally people in stage 1 and 2 of cancer do not suffer from neuroendocrine colon cancer. But alternately in the majority of cases if said tumour is in stage 3 or 4, it is a laborious and difficult task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has developed no adequate methods to treat this kind of cancer. A more common technique that doctors regularly use is immunohistochemical staining methods. This method helps doctors with coping with the severity of the neuroendocrine colon cancer and helps to determine the best medication and a treatment for it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumour with the antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and nature of the damage on the health of the patient.
Neuroendocrine colon carcinoma is difficult to treat and a case study in which a number of patients suffered from colon carcinoma were examined, an observation was made that the overall survival rate for this disease was in most cases, seven months. In a predominant stage these rates drop to less than five months. Most cases were originally seen as carcinoids but they soon became in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a poor prognosis and surgery may not be a perfect or even viable treatment so surgery may not provide a satisfactory cure. So this makes it important to detect this disease quickly and provide proper medication for it.
Caltrate Colon Health is important and for more information on Dukes C Colon Carcinoma.